IDXX241220P210000
- 3.25
- 0.000.00%
IDEXX Laboratories Inc Newsroom
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Jim Cramer on IDEXX Laboratories (IDXX): Is This Pet Stock Poised for a Comeback?
SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX
IDEXX Laboratories' (NASDAQ:IDXX) Earnings Growth Rate Lags the 9.3% CAGR Delivered to Shareholders
Unusual Options Activity: NVT, IDXX and Others Attract Market Bets, NVT V/OI Ratio Reaches 238.0
EST Dec 18th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $559
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
(IDXX) - Analyzing IDEXX Laboratories's Short Interest
IDEXX Laboratories Board Authorizes Increase In Its Ongoing Share Repurchase Program, Authorizing Repurchase Of Up To 5M Additional Shares
Express News | IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Estimating The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
A Glimpse Into The Expert Outlook On IDEXX Laboratories Through 5 Analysts
IDEXX Laboratories Analyst Ratings
Leerink Partners Initiates IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Announces Target Price $500
Express News | IDEXX Laboratories Inc : Leerink Partners Initiates Coverage With Outperform Rating; Price Target $500
Why Is IDEXX Laboratories, Inc. (IDXX) Among the Worst Performing Healthcare Stocks in 2024?
Executive Reshuffles: MFC, LYB, IDXX and TEX
IDEXX Laboratories Finance Chief Brian McKeon to Retire